The National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, has launched the Home Test to Treat program, an entirely virtual community health intervention that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities. The program, first announced by the White House (link is external) in September 2022, will make antiviral treatment available for eligible individuals who receive a positive test result, which could prevent severe illness, hospitalization or death.
“At-home testing for COVID-19 is now widely available in the United States, as are antiviral treatments, and this program combines easy home access to both,” said Bruce Tromberg, Ph.D., director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health and leader of the Rapid Acceleration of Diagnostics (RADx®) Tech program. “The Home Test to Treat program allows those who are sick an alternative to venturing out for testing or treatment, potentially reducing the spread of COVID-19 in the community.”
Later this month, local and state officials in Berks County, Pennsylvania, will be the first to pilot the Home Test to Treat program. Up to 8,000 eligible residents are anticipated to participate in the program…
NIBIB also has issued a contract with UMass Chan Medical School, whose researchers, in collaboration with eMed, will analyze data collected from each participating community, including the impacts of a home-based process for testing and treatment, individual attitudes about the Home Test to Treat program, and clinical outcomes from treatments.
HHS, through ASPR, has led a national COVID-19 Test to Treat initiative since March 2022, that includes thousands of treatment access points nationwide. These include CDC’s Increasing Community Access to Testing (ICATT) program, composed of federally funded health centers, long-term care facilities and community-based sites. Participants in the Home Test to Treat program can be tested at local ICATT centers. The Test to Treat initiative has evolved to include more mobile and telehealth-based models that reduce barriers to access for the highest-risk individuals. NIH’s Home Test to treat program will provide an important additional pathway to rapidly access lifesaving treatments for COVID-19 in vulnerable communities… Read the full press release here.